Donald Trump was inaugurated for his second term on January 20, 2025, so the first six months of his administration run roughly through July 20, 2025.(en.wikipedia.org)
Within that window, on May 12, 2025, the U.S. and China announced a Geneva trade deal and joint statement that dramatically rolled back the new, extremely high reciprocal tariffs that had been imposed in April. The agreement lowered the reciprocal tariff component on each side from around 125–145% to 10% for an initial 90-day period, cutting the U.S. general tariff rate on Chinese goods associated with that measure from 125% down to 10% (though a separate 20% “fentanyl” tariff and pre‑existing Section 301/232 tariffs remained).(whitehouse.gov) This is a very large reduction in the marginal tariff burden that had just been imposed on Chinese imports, i.e., a clear move to “minimize tariff impacts” relative to the peak levels Trump had created.
On the Chinese side, the same Geneva deal required Beijing to cut its tariffs on U.S. goods to 10% and to suspend or remove non‑tariff countermeasures and retaliatory duties that had been put in place after April 2, 2025.(whitehouse.gov) Rolling back those retaliatory tariffs and non‑tariff restrictions materially improves access for U.S. exporters and firms in the Chinese market compared with the pre‑deal situation.
Later, on November 1, 2025, a follow‑on Trump–Xi agreement went further: China committed to “open China’s market to U.S. soybeans and other agricultural exports,” end retaliation against U.S. semiconductor manufacturers and other companies, suspend wide‑ranging retaliatory tariffs and non‑tariff measures, and extend tariff‑exclusion processes, while the U.S. further reduced certain China‑related tariffs and extended its own exclusions.(whitehouse.gov) This later deal reinforces the same basic trade‑off: U.S. tariff relief in exchange for greater Chinese-market access for U.S. entities.
There is nuance—overall U.S. duties on Chinese goods remain elevated because Trump also imposed a general 10% baseline tariff and separate fentanyl‑related tariffs, and many Section 301/232 measures stayed in force.(businessinsider.com) But the prediction was about the structure of an early Trump‑term U.S.–China “grand deal”: the U.S. easing tariff pressure on Chinese imports in return for better access to China for U.S. firms. The May 12 Geneva agreement, occurring well within the first six months, matches that pattern closely—large negotiated cuts to new reciprocal tariffs paired with China rolling back retaliatory tariffs and other barriers on U.S. goods and companies.
Given that this core dynamic did in fact occur, the prediction is best classified as right, albeit with the caveat that much of the relief was partial and initially time‑limited rather than a complete, permanent dismantling of Trump’s China tariffs.